Greig NH - Search Results

1

Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4.

Perry T, Haughey NJ, Mattson MP, Egan JM, Greig NH. Perry T, et al. Among authors: greig nh. J Pharmacol Exp Ther. 2002 Sep;302(3):881-8. doi: 10.1124/jpet.102.037481. J Pharmacol Exp Ther. 2002. PMID: 12183643

2

Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats.

Wang Y, Perfetti R, Greig NH, Holloway HW, DeOre KA, Montrose-Rafizadeh C, Elahi D, Egan JM. Wang Y, et al. Among authors: greig nh. J Clin Invest. 1997 Jun 15;99(12):2883-9. doi: 10.1172/JCI119482. J Clin Invest. 1997. PMID: 9185511 Free PMC article.

3

The effects of GLP-1 on insulin release in young and old rats in the fasting state and during an intravenous glucose tolerance test.

De Ore K, Greig NH, Holloway HW, Wang Y, Perfetti R, Egan JM. De Ore K, et al. Among authors: greig nh. J Gerontol A Biol Sci Med Sci. 1997 Sep;52(5):B245-9. doi: 10.1093/gerona/52a.5.b245. J Gerontol A Biol Sci Med Sci. 1997. PMID: 9310073

4

Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations.

Greig NH, Holloway HW, De Ore KA, Jani D, Wang Y, Zhou J, Garant MJ, Egan JM. Greig NH, et al. Diabetologia. 1999 Jan;42(1):45-50. doi: 10.1007/s001250051111. Diabetologia. 1999. PMID: 10027577

5

Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats.

Szayna M, Doyle ME, Betkey JA, Holloway HW, Spencer RG, Greig NH, Egan JM. Szayna M, et al. Among authors: greig nh. Endocrinology. 2000 Jun;141(6):1936-41. doi: 10.1210/endo.141.6.7490. Endocrinology. 2000. PMID: 10830274

6

The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics.

Greig NH, De Micheli E, Holloway HW, Yu QS, Utsuki T, Perry TA, Brossi A, Ingram DK, Deutsch J, Lahiri DK, Soncrant TT. Greig NH, et al. Acta Neurol Scand Suppl. 2000;176:74-84. doi: 10.1034/j.1600-0404.2000.00311.x. Acta Neurol Scand Suppl. 2000. PMID: 11261809

7

A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide.

Culmsee C, Zhu X, Yu QS, Chan SL, Camandola S, Guo Z, Greig NH, Mattson MP. Culmsee C, et al. Among authors: greig nh. J Neurochem. 2001 Apr;77(1):220-8. doi: 10.1046/j.1471-4159.2001.t01-1-00220.x. J Neurochem. 2001. PMID: 11279278 Free article.

8

Insertion of an N-terminal 6-aminohexanoic acid after the 7 amino acid position of glucagon-like peptide-1 produces a long-acting hypoglycemic agent.

Doyle ME, Greig NH, Holloway HW, Betkey JA, Bernier M, Egan JM. Doyle ME, et al. Among authors: greig nh. Endocrinology. 2001 Oct;142(10):4462-8. doi: 10.1210/endo.142.10.8410. Endocrinology. 2001. PMID: 11564711

9

A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells.

Perry T, Lahiri DK, Chen D, Zhou J, Shaw KT, Egan JM, Greig NH. Perry T, et al. Among authors: greig nh. J Pharmacol Exp Ther. 2002 Mar;300(3):958-66. doi: 10.1124/jpet.300.3.958. J Pharmacol Exp Ther. 2002. PMID: 11861804

10

A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase.

Greig NH, Utsuki T, Yu Q, Zhu X, Holloway HW, Perry T, Lee B, Ingram DK, Lahiri DK. Greig NH, et al. Curr Med Res Opin. 2001;17(3):159-65. doi: 10.1185/0300799039117057. Curr Med Res Opin. 2001. PMID: 11900310 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters